These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11562311)

  • 1. Retinoids, apoptosis and cancer.
    Simoni D; Tolomeo M
    Curr Pharm Des; 2001 Nov; 7(17):1823-37. PubMed ID: 11562311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells.
    Simoni D; Roberti M; Invidiata FP; Rondanin R; Baruchello R; Malagutti C; Mazzali A; Rossi M; Grimaudo S; Capone F; Dusonchet L; Meli M; Raimondi MV; Landino M; D'Alessandro N; Tolomeo M; Arindam D; Lu S; Benbrook DM
    J Med Chem; 2001 Jul; 44(14):2308-18. PubMed ID: 11428925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoids: present role and future potential.
    Evans TR; Kaye SB
    Br J Cancer; 1999 Apr; 80(1-2):1-8. PubMed ID: 10389969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed cell death (PCD) associated with the stilbene motif of arotinoids: discovery of novel apoptosis inducer agents possessing activity on multidrug resistant tumor cells.
    Simoni D; Roberti M; Invidiata FP; Rondanin R; Baruchello R; Malagutti C; Mazzali A; Rossi M; Grimaudo S; Dusonchet L; Meli M; Raimondi MV; D'Alessandro N; Tolomeo M
    Bioorg Med Chem Lett; 2000 Dec; 10(23):2669-73. PubMed ID: 11128648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural retinoids inhibit proliferation and induce apoptosis in pancreatic cancer cells previously reported to be retinoid resistant.
    el-Metwally TH; Hussein MR; Pour PM; Kuszynski CA; Adrian TE
    Cancer Biol Ther; 2005 Apr; 4(4):474-83. PubMed ID: 15908778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoid related molecules an emerging class of apoptotic agents with promising therapeutic potential in oncology: pharmacological activity and mechanisms of action.
    Garattini E; Gianni M; Terao M
    Curr Pharm Des; 2004; 10(4):433-48. PubMed ID: 14965204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoids as chemopreventive agents.
    Ralhan R; Kaur J
    J Biol Regul Homeost Agents; 2003; 17(1):66-91. PubMed ID: 12757022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renaissance of the biologically active vitamin A derivatives: established and novel directed therapies for cancer and chemoprevention.
    Brtko J; Thalhamer J
    Curr Pharm Des; 2003; 9(25):2067-77. PubMed ID: 14529416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural and synthetic retinoids in prostate cancer.
    Pasquali D; Rossi V; Bellastella G; Bellastella A; Sinisi AA
    Curr Pharm Des; 2006; 12(15):1923-9. PubMed ID: 16724957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and stereoselective synthesis of retinoids with ferrocene or N-butylcarbazole pharmacophores that induce post-differentiation apoptosis in acute promyelocytic leukemia cells.
    Ivanova D; Gronemeyer H; de Lera AR
    ChemMedChem; 2011 Aug; 6(8):1518-29. PubMed ID: 21506276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of effective retinoids for inhibiting growth and inducing apoptosis in bladder cancer cells.
    Zou C; Liebert M; Zou C; Grossman HB; Lotan R
    J Urol; 2001 Mar; 165(3):986-92. PubMed ID: 11176527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy.
    Dobrotkova V; Chlapek P; Mazanek P; Sterba J; Veselska R
    BMC Cancer; 2018 Nov; 18(1):1059. PubMed ID: 30384831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis in ovarian carcinoma cells by AHPN/CD437 is mediated by retinoic acid receptors.
    Holmes WF; Dawson MI; Soprano RD; Soprano KJ
    J Cell Physiol; 2000 Oct; 185(1):61-7. PubMed ID: 10942519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-independent induction of apoptosis by synthetic retinoids.
    Lotan R
    J Biol Regul Homeost Agents; 2003; 17(1):13-28. PubMed ID: 12757019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classical and novel retinoids: their targets in cancer therapy.
    Fontana JA; Rishi AK
    Leukemia; 2002 Apr; 16(4):463-72. PubMed ID: 11960323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoids in cancer therapy and chemoprevention: promise meets resistance.
    Freemantle SJ; Spinella MJ; Dmitrovsky E
    Oncogene; 2003 Oct; 22(47):7305-15. PubMed ID: 14576840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The promise of retinoids to fight against cancer.
    Altucci L; Gronemeyer H
    Nat Rev Cancer; 2001 Dec; 1(3):181-93. PubMed ID: 11902573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative activity and apoptosis induced by retinoic acid receptor-gamma selectively binding retinoids in neuroblastoma.
    Meister B; Fink FM; Hittmair A; Marth C; Widschwendter M
    Anticancer Res; 1998; 18(3A):1777-86. PubMed ID: 9673404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoids as differentiating agents in oncology: a network of interactions with intracellular pathways as the basis for rational therapeutic combinations.
    Garattini E; Gianni M; Terao M
    Curr Pharm Des; 2007; 13(13):1375-400. PubMed ID: 17506722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoids and ovarian cancer.
    Zhang D; Holmes WF; Wu S; Soprano DR; Soprano KJ
    J Cell Physiol; 2000 Oct; 185(1):1-20. PubMed ID: 10942515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.